Mehra Anand bought ACRS
June 5, 2026 · Form 4 insider transaction
Mehra Anand bought 11,580 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,580
Price
N/A
Total value
N/A
InsiderMehra Anand
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after726,403
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.